These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

95 related articles for article (PubMed ID: 6754597)

  • 1. A sensitive assay for mutagenic activity of N-nitrosamines and its use for detection of modulators of the mutagenicity.
    Negishi T; Ohara Y; Hayatsu H
    IARC Sci Publ; 1982; (41):685-94. PubMed ID: 6754597
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Comparison of mutagenicities of N-nitrosamines on Salmonella typhimurium TA100 and Escherichia coli WP2 uvrA/pKM101 using rat and hamster liver s9.
    Araki A; Muramatsu M; Matsushima T
    Gan; 1984 Jan; 75(1):8-16. PubMed ID: 6373472
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Mutagenicity studies in Salmonella typhimurium on some carcinogenic N-nitramines in vitro and in the host-mediated assay in rats.
    Khudoley V; Malaveille C; Bartsch H
    Cancer Res; 1981 Aug; 41(8):3205-10. PubMed ID: 7018677
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Structure activity studies with N-nitrosamines using Salmonella typhimurium and Escherichia coli.
    Rao TK; Epler JL; Lijinsky W
    IARC Sci Publ; 1982; (41):543-51. PubMed ID: 6754596
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Inhibition by fatty acids of direct mutagenicity of N-nitroso compounds.
    Takeda K; Ukawa S; Mochizuki M
    IARC Sci Publ; 1991; (105):558-63. PubMed ID: 1855917
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Synthesis and mutagenicity of 4-(N-butylnitrosamino)-4-hydroxybutyric acid lactone, a possible activated metabolite of the proximate bladder carcinogen N-butyl-N-(3-carboxypropyl)nitrosamine.
    Mochizuki M; Irving CC; Anjo T; Wakabayashi Y; Suzuki E; Okada M
    Cancer Res; 1980 Jan; 40(1):162-5. PubMed ID: 6765916
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Optimizing the detection of N-nitrosamine mutagenicity in the Ames test.
    Heflich RH; Bishop ME; Mittelstaedt RA; Yan J; Guerrero SK; Sims AM; Mitchell K; Moore N; Li X; Mei N; Elespuru RK; King ST; Keire DA; Kruhlak NL; Dorsam RT; Raw AS; Davis Bruno KL; McGovern TJ; Atrakchi AH
    Regul Toxicol Pharmacol; 2024 Nov; 153():105709. PubMed ID: 39343352
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Formation, deoxygenation and mutagenicity of alpha-hydroperoxydialkylnitrosamines.
    Okada M; Mochizuki M; Anjo T; Sone T; Wakabayashi Y; Suzuki E
    IARC Sci Publ; 1980; (31):71-82. PubMed ID: 7014439
    [TBL] [Abstract][Full Text] [Related]  

  • 9. [Use of the bacterial flocculation test for assessing the mutagenic properties of carcinogenic nitrosamines and nitramines].
    Khudoleĭ VV
    Vopr Onkol; 1982; 28(8):64-8. PubMed ID: 7051551
    [TBL] [Abstract][Full Text] [Related]  

  • 10. The pH-dependent response of Salmonella typhimurium TA100 to mutagenic N-nitrosamines.
    Negishi T; Hayatsu H
    Mutat Res; 1980 Nov; 79(3):223-30. PubMed ID: 7012604
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Mutagenic activity of acrolein in S. typhimurium and E. coli.
    Parent RA; Caravello HE; San RH
    J Appl Toxicol; 1996; 16(2):103-8. PubMed ID: 8935782
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Formation of direct-acting mutagens from mixtures of N-nitrosomorpholine and carboxylates by UVA irradiation.
    Arimoto-Kobayashi S; Hayatsu H
    Environ Mol Mutagen; 1998; 31(2):163-8. PubMed ID: 9544194
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Mutagenicity of carbon tetrachloride and chloroform in Salmonella typhimurium TA98, TA100, TA1535, and TA1537, and Escherichia coli WP2uvrA/pKM101 and WP2/pKM101, using a gas exposure method.
    Araki A; Kamigaito N; Sasaki T; Matsushima T
    Environ Mol Mutagen; 2004; 43(2):128-33. PubMed ID: 14991753
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Chemistry and mutagenicity of alpha-hydroxy nitrosamines.
    Mochizuki M; Anjo T; Takeda K; Suzuki E; Sekiguchi N; Huang GF; Okada M
    IARC Sci Publ; 1982; (41):553-9. PubMed ID: 7141560
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Mutagenicity of N-nitroso bile acid conjugates in Salmonella typhimurium and diploid human lymphoblasts.
    Puju S; Shuker DE; Bishop WW; Falchuk KR; Tannenbaum SR; Thilly WG
    Cancer Res; 1982 Jul; 42(7):2601-4. PubMed ID: 7044521
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Mutagenicity arising from near-ultraviolet irradiation of N-nitrosomorpholine.
    Shimada H; Hayatsu H
    Mutat Res; 1985 Jul; 143(3):165-8. PubMed ID: 3892277
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Intermediate frequency magnetic fields do not have mutagenic, co-mutagenic or gene conversion potentials in microbial genotoxicity tests.
    Nakasono S; Ikehata M; Dateki M; Yoshie S; Shigemitsu T; Negishi T
    Mutat Res; 2008 Jan; 649(1-2):187-200. PubMed ID: 17997348
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Standardization of conditions for the metabolic activation of N-nitrosodiethylamine in mutagenicity tests.
    Aiub CA; Pinto LF; Felzenszwalb I
    Genet Mol Res; 2004 Jun; 3(2):264-72. PubMed ID: 15266397
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Directly-acting mutagens formed from N-nitroso-N-(formylmethyl)alkylamines.
    Suzuki E; Osabe M; Mochizuki M; Okada M
    IARC Sci Publ; 1987; (84):100-3. PubMed ID: 3315995
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Drug interactions. III. Formation of nitrosamines from therapeutic drugs. Formation, mutagenic properties and safety assessment of propranolol hydrochloride with respect to the intragastric formation of N-nitrosopropranolol under conditions found in patients.
    Raisfeld-Danse IH; Chen J
    J Pharmacol Exp Ther; 1983 Jun; 225(3):713-9. PubMed ID: 6345752
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 5.